|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
Executive Committee: Cornerstone Therapeutics, Inc.
| Manager | Title | Age | Since |
|---|---|---|---|
Jon Zwinski
CEO | Chief Executive Officer | - | 01/01/2021 |
| Chief Tech/Sci/R&D Officer | 76 | - |
Company details: Cornerstone Therapeutics, Inc.
Generic Pharmaceuticals
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.75% | -2.84% | +16.12% | +66.06% | 46.96B | |
| +0.12% | -1.59% | +47.86% | +123.16% | 39.63B | |
| -0.92% | -3.10% | -8.47% | +14.91% | 12.07B | |
| -0.86% | -8.19% | +11.81% | +69.39% | 11.61B | |
| +0.58% | 0.00% | +30.65% | +147.62% | 9.11B | |
| +0.70% | -0.08% | +21.23% | +41.06% | 7.47B | |
| +0.80% | +1.82% | +43.27% | -11.49% | 7.18B | |
| -3.31% | -2.62% | +14.61% | +187.72% | 6.79B | |
| -0.97% | -2.30% | -30.37% | +24.93% | 5.75B | |
| Average | -0.34% | -0.63% | +16.30% | +73.71% | 16.29B | |
| Weighted average by Cap. | +0.05% | -2.15% | +22.94% | +81.57% |
- Stock Market
- Stocks
- Stock
- Company Cornerstone Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
